Close-up of businessman explaining a financial plan to colleagues at meeting

Nic Inc (NASDAQ:EGOV)’s share price plunged -1.26% or -0.2 to reach at $15.7 during previous trading session. A total of 833080 shares exchanged hands, whereas the company’s average trading volume stands at 491.2 Million shares. Nic Inc (NASDAQ:EGOV) has a market capitalization of $1.03 Billion and most recently 65.64 Million outstanding shares have been calculated.

According to sentiments of 6 analysts the mean estimates of short term price target for the company’s stock is marked at $17.25. The most optimistic analyst sees the stock reaching $18.5 while the most conventional predicts the target price at $16.

In terms of Buy/Sell recommendations, 7 analysts have a consensus rating of 2.71 on the shares of Nic Inc (NASDAQ:EGOV). Out of rating recommendations 0 have given the stock a Buy while 1 recommend the stock as Outperform. 7 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Nic Inc (NASDAQ:EGOV)’s distance from 20 day simple moving average is -0.0611 along with distance from 50 day simple moving average of 16.99 whereas its distance from 200 day simple moving average is 18.06. Nic Inc (NASDAQ:EGOV)’s price distance from 52-week high is -39.38 and from 52-week low is 1.62. The stock hit its 52-week high price on 12/16/16, and 52-week low price on 08/18/17. The stock’s 52-week price fluctuated within the range of $25.90 – $15.45.

Nic Inc (NASDAQ:EGOV)’s shares slipped -1.57% in the past week and plunged -10.29% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -25.77% while its year to date performance is at -34.31%.

While taking a glance at financials, we can look at a number of key indicators. Nic Inc (NASDAQ:EGOV) has a Return on Assets (ROA) of 22.1. The company currently has a Return on Equity (ROE) of 36.9 and a Return on Investment (ROI) of 41.7. Average true range (ATR-14) of the company sets at 0.49, along with its weekly and monthly volatility of 2.04% and 3.05% respectively. Relative strength index (RSI-14) for Nic Inc (NASDAQ:EGOV) is at 33.28. Beta value of the stock stands at 0.4.

The company’s price to free cash flow for trailing twelve months is 36.03. Its quick ratio for most recent quarter is 2.6 along with current ratio for most recent quarter of 2.6. Total debt to equity ratio of Nic Inc (NASDAQ:EGOV) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0.

Shares of Adamas Pharma Cmn (NASDAQ:ADMS) soared 3.75% or 1.04 to reach at $28.79 during previous trading session. Adamas Pharma Cmn (NASDAQ:ADMS) has a market capitalization of $646.62 Million and most recently 22.46 Million outstanding shares have been calculated. A total of 909844 shares exchanged hands, whereas the company’s average trading volume stands at 1.28 Million shares.

According to 7 analysts Adamas Pharma Cmn (NASDAQ:ADMS)’s price will reach at $48.86 during 52 weeks. Stock’s minimum price target estimates has been figured out at $33 while the maximum price target forecast is established at $85.

According to the recommendations from 8 analysts stock has mean rating of 1 on the shares of Adamas Pharma Cmn (NASDAQ:ADMS). Out of rating recommendations 1 have given the stock a Buy while 7 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Adamas Pharma Cmn (NASDAQ:ADMS) climbed 4.88% in the past week and soared 51.37% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 88.42% while its year to date performance is at 70.36%.

Adamas Pharma Cmn (NASDAQ:ADMS)’s 52-week price fluctuated within the range of $29.29 – $13.50. Its price distance from 52-week high is -1.71 and from 52-week low is 113.26. The stock hit its 52-week high price on 11/03/17, and 52-week low price on 08/16/17. Adamas Pharma Cmn (NASDAQ:ADMS)’s distance from 20 day simple moving average is0.2618 along with distance from 50 day simple moving average of 22.16 whereas its distance from 200 day simple moving average is 18.65.

Total debt to equity ratio of Adamas Pharma Cmn (NASDAQ:ADMS) for most recent quarter is 0.41 whereas long term debt to equity ratio for most recent quarter is 0.41. The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 8.3 along with current ratio for most recent quarter of 8.3.

Average true range (ATR-14) of the company sets at 1.58, along with its weekly and monthly volatility of 4.73% and 6.27% respectively. Relative strength index (RSI-14) for Adamas Pharma Cmn (NASDAQ:ADMS) is at 73.39. Beta value of the stock stands at 0.82. Adamas Pharma Cmn (NASDAQ:ADMS) has a Return on Assets (ROA) of -53.8. The company currently has a Return on Equity (ROE) of -68 and a Return on Investment (ROI) of -46.